Clinical Core
Clinical Core
批准号:
10615163
负责人:
DOUGLAS R GALASKO
金额:
$99.71万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-03-31
关键词:
AddressAdoptedAgeAgingAgreementAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaAutopsyBiochemicalBiological MarkersBiopsyBloodBlood specimenBrainBrain ChemistryBrain imagingCellsCessation of lifeClassificationClinicalClinical ResearchCognitionCognitiveCognitive agingConsentDNADataData SetDatabasesDementiaDiagnosisDiseaseEarly DiagnosisElderlyEnrollmentEnvironmentExcisionFrontotemporal Lobar DegenerationsFundingGeneticHeterogeneityHippocampusHuman MicrobiomeImageLatinoLatino PopulationLewy Body DiseaseLinkMagnetic Resonance ImagingMeasuresMedical GeneticsMemoryMethodologyMexican AmericansMinority EnrollmentNeurodegenerative DisordersParticipantPathologyPersonsPhenotypePhysiologicalPlasmaPluripotent Stem CellsPopulationPositron-Emission TomographyQuality ControlRegistriesResearchResearch SupportSamplingSerumSkinSpinal PunctureStagingStructureSymptomsTestingUnited States National Institutes of HealthVariantWorkaging brainalpha synucleinbiomarker evaluationcell transformationclinical phenotypeclinical trial recruitmentclinically significantcognitive testingcohortdata managementdata sharingdementia riskfollow-uphazardhippocampal sclerosisindexinginduced pluripotent stem cellinnovationinterestmeetingsmembermetabolomicsmild cognitive impairmentminority subjectsneuropathologynovelnovel markeroutreachpre-clinicalrecruitresponsesocialsymposiumtau Proteinsvolunteer
中文摘要
临床核心总结/摘要
临床核心的主要目标是招募、描述和跟踪维持在500-600人的队列
老年人支持对阿尔茨海默病和相关疾病的多种类型的研究。的人
参加的人将包括一些认知正常的人,其中一些人的大脑中可能有阿尔茨海默氏症的标记
已经有轻度认知障碍和轻度阿尔茨海默氏症患者,以及其他类型的
神经退行性疾病,包括路易体病和额颞叶变性。的
核心将招收少数民族科目作为被跟踪的群体的一部分,特别是拉丁美洲人。
除了收集和存储有关加州大学圣地亚哥分校ADRC参与者的数据外,核心还包括
这些组件是跨中心的国家努力的一部分,称为统一数据集(UDS)。芯会
将所有受试者的UDS数据提交给国家阿尔茨海默氏症协调中心(NACC)。这将
允许与大型国家数据库共享数据。临床中心将在
UDS所需的测试。
核心将从参与者中抽取血液样本用于DNA、血浆和血清,并将获得CSF
从同意的人身上进行腰椎穿刺。核心将获得皮肤活检,用于转化
将皮肤中的细胞转化为可以转变为多种身份的细胞(称为多能干细胞)。参与者
将有MRI脑成像和PET成像,以支持对大脑变化和病理学的研究。血,
CSF、皮肤活检和成像将储存在UCSD,以进行进一步分析,
与合作者分享。
所有参与者将被邀请每年进行一次后续研究评估,以确定
大脑功能、记忆力和其他能力的改变。在同意的受试者中,在他们死后,
安排进行脑部解剖、病理分析和支持进一步研究。
核心将集中精力的一些特定领域是新颖的认知测试和评估
通过与脑的结构、功能、病理学和化学相关的生物标志物来研究脑。这可以帮助
在痴呆症的主要症状出现之前及早发现变化。老年痴呆症有不同的
特征和进展以不同的速度,我们将试图确定可能导致这种变化的因素。
核心感兴趣的另一个领域是开发更好的方法来评估拉丁美洲参与者,
通过社会,文化,和研究的拉丁美洲核心的专业知识。
最后,核心将与ADRC的其他成员合作,维护和扩大研究登记册-
志愿者准备
英文摘要
CLINICAL CORE SUMMARY/ ABSTRACT
The primary aim of the Clinical Core will be to enroll, characterize and follow a cohort maintained at 500-600
elders to support many types of research into Alzheimer’s Disease and Related Disorders. People who are
enrolled will include some with normal cognition, some of whom may have markers of Alzheimer’s in their brain
already, people with mild cognitive impairment and mild Alzheimer’s, and people with other types of
neurodegenerative disorders, including Lewy Body Disease and Fronto-Temporal Lobar Degeneration. The
core will enroll minority subjects as part of the groups that are followed, in particular Latinos.
In addition to collecting and storing data about the ADRC participants at UCSD, the core will include
components that are part of a national effort across centers, called the Uniform Data Set (UDS). The Core will
submit UDS data on all subjects it follows to the national Alzheimer’s Coordinating Center (NACC). This will
allow data sharing with a large national database. The Clinical Core will perform further testing beyond the
tests required for the UDS.
The core will draw a sample of blood for DNA, plasma and serum from participants, and will obtain CSF
samples by lumbar puncture from those who agree. The core will obtain skin biopsies to be used to transform
the cells in the skin into cells that can change into many identities (called pluripotent stem cells). Participants
will have MRI brain imaging and PET imaging to support research into brain changes and pathology. Blood,
CSF, skin biopsies and imaging will be stored at UCSD to allow for further analysis, and it may be available to
share with collaborators.
All participants will be invited to undergo follow-up research assessments once per year, to determine
change in brain functioning, memory and other abilities. In subjects who consent, after their death the core will
arrange for autopsy removal of the brain, for pathology analysis and to support further research.
Some of the particular areas where the core will focus its efforts are in novel cognitive tests and assessing the
brain through biomarkers related to structure, function, pathology and chemistry of the brain. This may help in
early detection of change before major symptoms of dementia have arisen. Alzheimer’s disease has different
features and progresses at varying rates, and we will try to identify factors that may account for this variation.
Another area of interest for the core is in developing better ways to assess Latino participants, supported
through social, cultural, and research expertise of the Latino Core.
Finally, the core will work with other members of the ADRC to maintain and expand a Registry of research-
ready volunteers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
-
批准号:10335246
-
项目类别:
-
资助金额:$252.2万
-
财政年份:2021
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Clinical Core
-
批准号:10407979
-
项目类别:
-
资助金额:$114.83万
-
财政年份:2019
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's Disease
-
批准号:10407966
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2018
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's Disease
-
批准号:10153614
-
项目类别:
-
资助金额:$78.98万
-
财政年份:2018
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:10673098
-
项目类别:
-
资助金额:$212.77万
-
财政年份:2016
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:10531287
-
项目类别:
-
资助金额:$209.1万
-
财政年份:2016
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Core A: Administrative Core
-
批准号:8676141
-
项目类别:
-
资助金额:$66.81万
-
财政年份:2014
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Clinical Core
-
批准号:8676142
-
项目类别:
-
资助金额:$92.69万
-
财政年份:2014
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Translational Center for Alzheimer's Disease Target and Drug Discovery
-
批准号:8849662
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2014
-
负责人:DOUGLAS R GALASKO
-
依托单位:
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD
-
批准号:7197191
-
项目类别:
-
资助金额:$59.93万
-
财政年份:2006
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:7112234
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:6804444
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:6940622
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:6725034
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Biomarkers in Aging, MCI and Alzheimer's Disease
-
批准号:7277121
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2003
-
负责人:DOUGLAS R GALASKO
-
依托单位:
CLINICAL STUDIES OF NSAIDSs AS y-SECRETASE MODULATORS IN ALZHEIMER'S DISEASE
-
批准号:7568359
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2002
-
负责人:DOUGLAS R GALASKO
-
依托单位:
AGE RELATED NEURODEGENERATIVE DISEASES IN MICRONESIA
-
批准号:6163783
-
项目类别:
-
资助金额:$183.35万
-
财政年份:1997
-
负责人:DOUGLAS R GALASKO
-
依托单位:
CORE---ADMINISTRATIVE, DATABASE, AND STATISTICAL
-
批准号:6481377
-
项目类别:
-
资助金额:$17.79万
-
财政年份:1997
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:8051780
-
项目类别:
-
资助金额:$293.08万
-
财政年份:1997
-
负责人:DOUGLAS R GALASKO
-
依托单位:
Alzheimer's Disease Research Center
-
批准号:7210679
-
项目类别:
-
资助金额:$267.96万
-
财政年份:1997
-
负责人:DOUGLAS R GALASKO
-
依托单位:
海外基金